CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,266 | +7.7% | 27,023 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $28,104 | -7.1% | 27,023 | 0.0% | 0.01% | -10.0% |
| Q4 2022 | $30,266 | -2.4% | 27,023 | 0.0% | 0.01% | +100.0% |
| Q3 2022 | $31,000 | -50.0% | 27,023 | 0.0% | 0.01% | -58.3% |
| Q1 2022 | $62,000 | -12.7% | 27,023 | +4.6% | 0.01% | -45.5% |
| Q4 2021 | $71,000 | -45.0% | 25,823 | +20.0% | 0.02% | -40.5% |
| Q3 2021 | $129,000 | +126.3% | 21,523 | -6.5% | 0.04% | +76.2% |
| Q1 2021 | $57,000 | – | 23,023 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |